title: Intratumoral patterns of genomic imbalance in glioblastomas.
abstract: Glioblastomas are morphologically and genetically heterogeneous, but little is known about the regional patterns of genomic imbalance within glioblastomas. We recently established a reliable whole genome amplification (WGA) method to randomly amplify DNA from paraffin-embedded histological sections with minimum amplification bias [Huang et al (J Mol Diagn 11: 109-116, 2009)]. In this study, chromosomal imbalance was assessed by array comparative genomic hybridization (CGH; Agilent 105K, Agilent Technologies, Santa Clara, CA, USA), using WGA-DNA from two to five separate tumor areas of 14 primary glioblastomas (total, 41 tumor areas). Chromosomal imbalances significantly differed among glioblastomas; the only alterations that were observed in > or =6 cases were loss of chromosome 10q, gain at 7p and loss of 10p. Genetic alterations common to all areas analyzed within a single tumor included gains at 1q32.1 (PIK3C2B, MDM4), 4q11-q12 (KIT, PDGFRA), 7p12.1-11.2 (EGFR), 12q13.3-12q14.1 (GLI1, CDK4) and 12q15 (MDM2), and loss at 9p21.1-24.3 (p16(INK4a)/p14(ARF)), 10p15.3-q26.3 (PTEN, etc.) and 13q12.11-q34 (SPRY2, RB1). These are likely to be causative in the pathogenesis of glioblastomas (driver mutations). In addition, there were numerous tumor area-specific genomic imbalances, which may be either nonfunctional (passenger mutations) or functional, but constitute secondary events reflecting progressive genomic instability, a hallmark of glioblastomas.
authors.affiliation: International Agency for Research on Cancer, Lyon, France.
authors.forename: Sumihito
authors.initials: S
authors.lastname: Nobusawa
authors.forename: Joel
authors.initials: J
authors.lastname: Lachuer
authors.forename: Anne
authors.initials: A
authors.lastname: Wierinckx
authors.forename: Young Ho
authors.initials: YH
authors.lastname: Kim
authors.forename: Jian
authors.initials: J
authors.lastname: Huang
authors.forename: Catherine
authors.initials: C
authors.lastname: Legras
authors.forename: Paul
authors.initials: P
authors.lastname: Kleihues
authors.forename: Hiroko
authors.initials: H
authors.lastname: Ohgaki
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000235:genetics*; D002869:Chromosome Aberrations; D055028:Comparative Genomic Hybridization / Q000379:methods*; D005260:Female; D015894:Genome, Human; D005909:Glioblastoma / Q000235:genetics*; D006801:Humans; D019656:Loss of Heterozygosity / Q000235:genetics; D008297:Male; D008875:Middle Aged; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics / Q000378:metabolism; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics; D015203:Reproducibility of Results
chemical_list: D020796:Receptor, Platelet-Derived Growth Factor alpha; C494918:AKT1 protein, human; D051057:Proto-Oncogene Proteins c-akt
references.citation: J Neuropathol Exp Neurol. 2006 Sep;65(9):846-54
references.pmid: 16957578
references.citation: Cancer Res. 2004 Oct 1;64(19):6892-9
references.pmid: 15466178
references.citation: Brain Tumor Pathol. 2003;20(2):59-63
references.pmid: 14756442
references.citation: Acta Neuropathol. 2007 Aug;114(2):97-109
references.pmid: 17618441
references.citation: Science. 2006 Oct 13;314(5797):268-74
references.pmid: 16959974
references.citation: J Pathol. 2005 Oct;207(2):224-31
references.pmid: 16021678
references.citation: BMC Genomics. 2006 Aug 23;7:216
references.pmid: 16928277
references.citation: Acta Neuropathol. 1996 Jul;92(1):70-4
references.pmid: 8811128
references.citation: Annu Rev Med. 2009;60:167-79
references.pmid: 19630570
references.citation: Nature. 2008 Oct 23;455(7216):1061-8
references.pmid: 18772890
references.citation: J Mol Diagn. 2009 Mar;11(2):109-16
references.pmid: 19197000
references.citation: Science. 2008 Sep 26;321(5897):1801-6
references.pmid: 18772397
references.citation: J Neuropathol Exp Neurol. 1998 Jul;57(7):684-9
references.pmid: 9690672
references.citation: Brain Pathol. 2003 Oct;13(4):630-8
references.pmid: 14655766
references.citation: Am J Pathol. 2001 May;158(5):1623-31
references.pmid: 11337360
references.citation: J Neurooncol. 2000 May;48(1):1-12
references.pmid: 11026691
references.citation: Science. 2008 Sep 26;321(5897):1807-12
references.pmid: 18772396
references.citation: Mol Cancer Res. 2006 Jul;4(7):471-9
references.pmid: 16849522
references.citation: Cancer Res. 1998 Oct 15;58(20):4694-700
references.pmid: 9788624
references.citation: Apoptosis. 2004 Nov;9(6):667-76
references.pmid: 15505410
references.citation: Cancer. 2004 Nov 15;101(10):2318-26
references.pmid: 15470710
references.citation: Am J Pathol. 2009 Apr;174(4):1149-53
references.pmid: 19246647
references.citation: Cancer Sci. 2009 Dec;100(12):2235-41
references.pmid: 19737147
references.citation: J Neuropathol Exp Neurol. 2001 Nov;60(11):1099-104
references.pmid: 11706939
references.citation: Am J Pathol. 2001 Apr;158(4):1253-62
references.pmid: 11290543
references.citation: Clin Cancer Res. 2009 Oct 1;15(19):6002-7
references.pmid: 19755387
references.citation: Genetics. 2006 Aug;173(4):2187-98
references.pmid: 16783027
references.citation: J Neuropathol Exp Neurol. 1999 Sep;58(9):993-9
references.pmid: 10499441
references.citation: Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14676-9
references.pmid: 8962113
references.citation: Science. 2007 Nov 16;318(5853):1108-13
references.pmid: 17932254
references.citation: Cancer Res. 2000 Oct 1;60(19):5405-9
references.pmid: 11034080